Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly. Most people with liver disease are symptom-free until complications like ...

Though it is predicted to become a top cause of organ damage and liver transplants within this decade, treatments for nonalcoholic fatty liver disease, or NAFLD, have stalled for a simple reason: It ...

A recent study at the Medical University of South Carolina's (MUSC) Digestive Disease Research Core Center (DDRCC) provides insight into why physicians should be cautious when using a certain liver ...

Novel non-invasive liver disease assessments (NILDAs) can effectively replace liver biopsy for assessing liver fibrosis in ...

A blood test looking for five specific proteins can predict metabolic dysfunction-associated steatotic liver disease, more commonly known as fatty liver disease, researchers are scheduled to report at ...

Please provide your email address to receive an email when new articles are posted on . Intelligent liver function testing successfully identified patients with hepatitis C who were previously ...

Cancer diagnostics firm Helio Genomics says its five-year clinical trial shows its AI-based diagnostic test is two to four times more effective than typical ultrasounds. Helio’s pivotal trial, which ...

Please provide your email address to receive an email when new articles are posted on . Vibration-controlled transient elastography and fibrosis-4 index are effective alternatives to liver biopsy when ...

BOSTON — In the staging of liver fibrosis in the post-liver transplant setting, readings from noninvasive tests commonly have major discrepancies when compared with liver biopsy results, particularly ...

Lucknow: Hepatic venous pressure gradient (HVPG), special medical test to gauge pressure inside liver, was performed for the ...